Abvc Biopharma Inc (ABVC) Live Share Price, Invest From India

Abvc Biopharma Inc Stock Performance

as on February 5, 2026 at 12:36 am IST

Day's High
$1.83
Day's Price Range
$1.90
$1.83
3.83%
Upside
52 Week's Low
52 Week's High
$0.40
52-Week Price Range
$5.48
$1.83
78.14%
Downside
199.45%
Upside

Abvc Biopharma Inc share price movements today

Previous Close: $1.90
Open: $1.89
Volume: 184.4K
Day's Low - High: $1.83 - $1.90
52 Week Low - High: $0.40 - $5.48

Abvc Biopharma Inc Historical Returns

1 Month Return: -13.24 %
3 Month Return: -32.62 %
1 Year Return: + 295.5 %
3 Year Return: -72.98 %
5 Year Return: 0 %

Abvc Biopharma Inc Stock Fundamentals & Key Indicators

Check Abvc Biopharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$50.3M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-4.9M

Revenue (TTM)

797.9K

Profit Margin

0.00%

Return On Equity TTM

-47.71%

Abvc Biopharma Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Abvc Biopharma Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Abvc Biopharma Inc	SELL	$50.3M	NA	NA	0.00%
Vertex Pharmaceuticals Incorporated	BUY	$122.3B	117.87%	33.56	31.35%
Alnylam Pharmaceuticals, Inc.	BUY	$47.7B	122.79%	1246.03	1.36%
Beone Medicines Ltd	NA	$37.4B	NA	662.33	1.38%
Regeneron Pharmaceuticals, Inc.	BUY	$80.8B	52.19%	18.28	32.13%

Stock Returns calculator for Abvc Biopharma Inc Stock including INR - Dollar returns

The Abvc Biopharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Abvc Biopharma Inc investment value today

Current value as on today

₹3,85,123

Returns

₹2,85,123

(+285.12%)

Returns from Abvc Biopharma Inc Stock

₹2,81,250 (+281.25%)

Dollar Returns*

₹3,873 (+3.87%)

Analyst Recommendation on Abvc Biopharma Inc Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Abvc Biopharma Inc. Average target price of $2.02

Abvc Biopharma Inc Share Price Target

Get share price movements and forecasts by analysts on Abvc Biopharma Inc.

What analysts predicted

9.41%UPSIDE

Target Price

$2.02

Current Price

$1.83

Analyzed by

6 Analysts

Target

$2.02

Abvc Biopharma Inc target price $2.02, a slight upside of 9.41% compared to current price of $1.83. According to 6 analysts rating.

Abvc Biopharma Inc Stock’s Investor Sentiment and Interest

Search interest for Abvc Biopharma Inc Stock has increased by 169% in the last 30 days, reflecting an upward trend in search activity.

Time period: January 6, 2026 to February 5, 2026

Change:169% versus previous 30 day period

Abvc Biopharma Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	0	0	0	0	0	0	0	0	-	0
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-2	-2	-1	-2	0	0	0	0	-2	-1
EBITDA	-2	-2	-2	-2	0	0	-	0	-2	-1
Interest Expense	0	1	1	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-2	-3	-3	-2	-1	0	0	0	-2	-1
Income Tax Expense	0	0	0	-3	0	0	-	-	0	0
Net Income	-2	-3	-3	-2	0	0	0	0	-2	-1
Net Profit Margin	-37052.07%	-20885.90%	-143692.10%	-235203.24%	-804.44%	-47.93%	11663.48%	-42831.89%	0.00%	-156.61%

Abvc Biopharma Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Sep 2017	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	-	0	0	0	0	0	0	0	0
Gross Profit	0	-	0	0	0	0	0	0	0	0
Operating Income	-10	-	-4	-2	-3	-8	-11	-15	-6	-4
EBITDA	-10	-	-4	-5	-3	-10	-10	-15	-6	-4
Interest Expense	0	-	0	0	0	0	0	0	1	0
Depreciation	-	-	0	-	0	0	0	0	0	0
Income Before Tax	-11	-	-4	-6	-4	-10	-11	-15	-8	-5
Income Tax Expense	0	-	0	0	0	0	0	0	0	0
Net Income	-11	-4	-4	-5	-3	-9	-12	-16	-7	-4
Net Profit Margin	-34399184.38%	0.00%	-132755.32%	-80152.08%	-518.98%	-2026.97%	-3608.47%	-1693.50%	-5109.26%	-962.12%

Abvc Biopharma Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Mar 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-3	-2	0	0	0	-2	-1
Operating Cash Flow	-1	0	0	0	0	0	0
Investing Cash Flow	0	-	-	-	-	0	-1
Financing Cash Flow	1	0	0	0	0	1	1
Change in Cash	0	0	0	0	0	0	0

Abvc Biopharma Inc Annual Cash Flow

All numbers in Millions USD

	Sep 2017	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-4	-6	-4	-3	-10	-12	-16	-7	-5
Operating Cash Flow	-1	-1	0	-3	-4	-7	-7	-4	-1
Investing Cash Flow	0	-7	0	0	0	0	-1	0	-
Financing Cash Flow	1	9	0	3	9	9	4	3	1
Change in Cash	0	0	0	0	4	1	-5	0	0

Global Institutional Holdings in Abvc Biopharma Inc

Funds	Holdings
Bank of America Corp	0%
Honkamp Krueger Financial Services Inc	0%
Renaissance Technologies Corp	0.18%
State Street Corp	0.05%
Virtu Financial LLC	0%

See all

Insights on Abvc Biopharma Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -2.25M → -1.24M (in $), with an average increase of 81.1% per quarter
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, ABVC has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 1.96K → 795.95K (in $), with an average increase of 99.8% per quarter
POSITIVE IMPACT
Price Rise
In the last 1 year, ABVC stock has moved up by 295.5%
NO EFFECT
Against Peers
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 34.8% return, outperforming this stock by 107.8%

About Abvc Biopharma Inc

american brivision (holding) corporation, a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the united states. the company is developing abv-1501, a combination therapy for triple negative breast cancer; abv-1504 for major depressive disorders; abv-1505 for attention deficit hyperactivity disorder; abv-1703 for the treatment of pancreatic cancer; abv-1702 to treat myelodysplastic syndromes; and abv-1601 for treating depression in cancer patients. it has a co-development agreement with rgene corporation; collaboration agreement with biohopeking corporation to develop abv-1501; and collaborative agreement with biofirst corporation to co-develop bfc-1401 vitreous substitute for vitrectom; and license with biofirst corporation to research and develop a medical device, abv-1701 vitargus for the treatment of retinal detachment or vitreous hemorrhage. the company was founded in 2015 and is based in fremont, california. american br

Organisation	Abvc Biopharma Inc
Headquarters	44370 Old Warm Springs Boulevard, Fremont, CA, United States, 94538
Industry	Industrial Specialties
CEO	Dr. Uttam Yashwant Patil Ph.D.
E-voting on shares	Click here to vote

Key Management of Abvc Biopharma Inc

Name	Title
Dr. Uttam Yashwant Patil Ph.D.	CEO & Interim CFO
Dr. Tsung-Shann Jiang EMBA, Ph.D.	Chief Scientific Officer, Chief Strategy Officer & Director
Mr. Eugene Jiang	Chairman & Chief Business Officer

FAQs

What is Abvc Biopharma Inc share price today?

Abvc Biopharma Inc share price today is $1.83 as on February 5, 2026 at 12:36 am IST. Abvc Biopharma Inc share today touched a day high of $1.9 and a low of $1.83.

What is the 52 week high and 52 week low for Abvc Biopharma Inc share?

Abvc Biopharma Inc share touched a 52 week high of $5.48 on July 8, 2025 and a 52 week low of $0.4 on February 10, 2025. Abvc Biopharma Inc stock price today i.e. February 5, 2026 at 12:36 am IST is trending at $1.83,which is 66.61% down from its 52 week high and 357.50% up from its 52 week low.

What is Abvc Biopharma Inc's market capitalisation today?

Abvc Biopharma Inc market capitalisation is $0.00T as on February 5, 2026 at 12:36 am IST.

How to invest in Abvc Biopharma Inc Stock (ABVC) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Abvc Biopharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Abvc Biopharma Inc Shares that will get you 0.8197 shares as per Abvc Biopharma Inc share price of $1.83 per share as on February 5, 2026 at 12:36 am IST.

What is the minimum amount required to buy Abvc Biopharma Inc Stock (ABVC) from India?

Indian investors can start investing in Abvc Biopharma Inc (ABVC) shares with as little as ₹90.453 or $1 (as of February 5, 2026 at 12:38 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹904.53 in Abvc Biopharma Inc stock (as per the Rupee-Dollar exchange rate as on February 5, 2026 at 12:38 am IST). Based on Abvc Biopharma Inc share’s latest price of $1.83 as on February 5, 2026 at 12:36 am IST, you will get 5.4645 shares of Abvc Biopharma Inc. Learn more about fractional shares .